🔎 Trials Near Me

Dachaigh › Lymphoma Hodgkin › Texas

Sgrùdaidhean clionaigeach Lymphoma Hodgkin ann an Texas

Tha 15 sgrùdaidhean airson Lymphoma Hodgkin a’ lorg phàirtichean aig làraichean ann an Texas.

Bailtean ann an Texas

Teacsa sgrùdaidh oifigeil (Beurla)

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
A’ fastadhÌre 1
Aoisean 12 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06176690

CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
A’ fastadhÌre 1
Aoisean 12 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT02917083

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

  • Texas Children's Hospital, Houston
A’ fastadhSgrùdadh amharc
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

  • M D Anderson Cancer Center, Houston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT05615636

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • Sarah Cannon Research Institute at St. David's South Austin, Austin
A’ fastadhÌre 1
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  • Research Site, Houston
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06137144

Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies

  • The University of Texas M. D. Anderson Cancer Center, Houston
A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07444632

Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

  • UT MD Anderson, Houston
A’ fastadhÌre 2
Aoisean 2 gu 21 · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT07551583

Personalized NK Cell Therapy in CBT

  • M D Anderson Cancer Center, Houston
A’ fastadhÌre 2
Aoisean 15 gu 80 · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT02727803

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Medical City Dallas, Dallas
  • Children's Medical Center Dallas, Dallas
  • Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
  • agus 5 a bharrachd
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

  • Harris Health System - Ben Taub General Hospital/Smith Clinic, Houston
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
  • agus 1 a bharrachd
A’ fastadhÌre 1
Gach aois · Gach gnè · Air ùrachadh 25 Ògmh 2026 · NCT04664179

A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma

  • MD Anderson Cancer Center, Houston
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Aoisean 1 agus nas sine · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT05355051

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • Harris Health System (includes ben Taub General Hospital and Smith), Houston
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
A’ fastadhÌre 1
Gach aois · Gach gnè · Air ùrachadh 2 Màrt 2026 · NCT01555892

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • University of Texas, Southwestern, Dallas
  • Cook Children's Hospital, Fort Worth
  • Texas Children's Hospital/Baylor College of Medicine, Houston
A’ fastadhÌre 1
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 6 Dùbh 2024 · NCT05476770

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.